Vull donar

JOSEP PUIG ALCÁNTARA

Firma
JOSEP PUIG-ALCÁNTARA
Posició
Investigador/a Consolidat - R3

Projectes

Codi oficial: La Marató 201725.30 Data inici: 10/03/2019 Data fi: 31/01/2022 Investigador/a principal: JOSEP PUIG ALCÁNTARA Organisme finançador: FUNDACIO LA MARATO TV3 Ajuda: 88,250 €
Codi oficial: GO03-001848 Data inici: 01/01/2017 Data fi: 31/12/2021 Investigador/a principal: JOSEP PUIG ALCÁNTARA Organisme finançador: GENERALITAT DE CATALUNYA Ajuda: 710,188.80 €
Codi oficial: 875534 Data inici: 09/07/2020 Data fi: 08/07/2025 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION Ajuda: 300,000 €
Codi oficial: RD16/0015/0006 Data inici: 01/01/2017 Data fi: 31/12/2021 Investigador/a principal: LLUÍS RAMIÓ I TORRENTÀ Organisme finançador: INSTITUTO DE SALUD CARLOS III Ajuda: 5,500 €
Codi oficial: EFA345/19 Data inici: 01/04/2020 Data fi: 31/05/2022 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: CONSORCIO DE LA CTP. INTERREG POCTEFA Ajuda: 599,974.98 €
Codi oficial: SMARTAGE Data inici: 01/09/2020 Data fi: 31/08/2024 Investigador/a principal: JOSÉ MANUEL FERNÁNDEZ-REAL LEMOS Organisme finançador: EUROPEAN COMISSION Ajuda: 417,569.76 €

Publicacions

Esteve-Codina A, Alameda F, Carrato C, Pineda E, Arpí O, Martinez Garcia M, Mallo M, Gut M, Dabad M, Tortosa A, Del Barco S, Capellades J, Puig J, Gallego O, Pujol T, Oleaga L, Gil-Gil MJ, de Quintana-Schmidt C, Valduvieco I, Martinez-Cardus A, Bellosillo B, Muñoz-Mármol AM, Esteve A, Domenech M, Camins A, Craven-Bartle J, Villa S, Marruecos J, Domenech S, de la Iglesia N, Balana C

RNA-Sequencing and immunohistochemistry reveal ZFN7 as a stronger marker of survival than molecular subtypes in G-CIMP-negative glioblastoma.

CLINICAL CANCER RESEARCH, 2021, 27, 645-655 dx.doi.org/10.1158/1078-0432.CCR-20-2141

Escrichs A, Biarnes C, Garre-Olmo J, Fernández-Real JM, Ramos R, Pamplona R, Brugada R, Serena J, Ramió-Torrentà L, Coll-De-Tuero G, Gallart L, Barretina J, Vilanova JC, Mayneris-Perxachs J, Essig M, Figley CR, Pedraza S, Puig J, Deco G

Whole-Brain Dynamics in Aging: Disruptions in Functional Connectivity and the Role of the Rich Club.

CEREB CORTEX, 2021, 31, 2466-2481 dx.doi.org/10.1093/cercor/bhaa367

Garre-Olmo J, Turró-Garriga O, Martí-Lluch R, Zacarías-Pons L, Alves-Cabratosa L, Serrano-Sarbosa D, Vilalta-Franch J, Ramos R, Girona Healthy Region Study Group

Changes in lifestyle resulting from confinement due to COVID-19 and depressive symptomatology: A cross-sectional a population-based study.

COMPR PSYCHIAT, 2021, 104, 152214-152214 dx.doi.org/10.1016/j.comppsych.2020.152214

Jensen M, Boutitie F, Cheng B, Cho TH, Ebinger M, Endres M, Fiebach JB, Fiehler J, Ford I, Galinovic I, Königsberg A, Puig J, Roy P, Wouters A, Thijs V, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Gerloff C, Thomalla G

Polypharmacy, functional outcome and treatment effect of intravenous alteplase for acute ischaemic stroke.

EUR J NEUROL, 2021, 28, 532-539 dx.doi.org/10.1111/ene.14566

Ohara T, Menon BK, Al-Ajlan FS, Horn M, Najm M, Al-Sultan A, Puig J, Dowlatshahi D, Calleja Sanz AI, Sohn SI, Ahn SH, Poppe AY, Mikulik R, Asdaghi N, Field TS, Jin A, Asil T, Boulanger JM, Letteri F, Dey S, Evans JW, Goyal M, Hill MD, Almekhlafi M, Demchuk AM, for INTERRSeCT Study Investigators

Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT Study.

Stroke, 2021, 52, 203-212 dx.doi.org/10.1161/STROKEAHA.120.029292

Mota-Martorell N, Jové M, Borrás C, Berdún R, Obis È, Sol J, Cabré R, Pradas I, Galo-Licona JD, Puig J, Viña J, Pamplona R

Methionine transsulfuration pathway is upregulated in long-lived humans.

FREE RADICAL BIO MED, 2021, 162, 38-52 dx.doi.org/10.1016/j.freeradbiomed.2020.11.026

Barow E, Boutitie F, Cheng B, Cho TH, Ebinger M, Endres M, Fiebach JB, Fiehler J, Nickel A, Puig J, Roy P, Lemmens R, Thijs V, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Gerloff C, Thomalla G

24-hour blood pressure variability and treatment effect of intravenous alteplase in acute ischaemic stroke.

European Stroke Journal, 2021, 6, 168-175 dx.doi.org/10.1177/23969873211014758

Cheng B, Boutitie F, Nickel A, Wouters A, Cho TH, Ebinger M, Endres M, Fiebach JB, Fiehler J, Galinovic I, Puig J, Thijs V, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Gerloff C, Thomalla G, WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis inWake-Up Stroke Trial) i

Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial.

Stroke, 2020, 51, 209-215 dx.doi.org/10.1161/STROKEAHA.119.027390

Barow E, Boutitie F, Cheng B, Cho TH, Ebinger M, Endres M, Fiebach JB, Fiehler J, Ford I, Galinovic I, Nickel A, Puig J, Roy P, Wouters A, Thijs V, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Gerloff C, Thomalla G, WAKE-UP investigators

Clinical Characteristics and Outcome of Patients with Lacunar Infarcts and Concurrent Embolic Ischemic Lesions.

CLINICAL NEURORADIOLOGY, 2020, 30, 511-516 dx.doi.org/10.1007/s00062-019-00800-5

Puig J, Shankar J, Liebeskind D, Terceño M, Nael K, Demchuk AM, Menon B, Dowlatshahi D, Leiva-Salinas C, Wintermark M, Thomalla G, Silva Y, Serena J, Pedraza S, Essig M

From "Time is Brain" to "Imaging is Brain": A Paradigm Shift in the Management of Acute Ischemic Stroke.

J NEUROIMAGING, 2020, 30, 562-571 dx.doi.org/10.1111/jon.12693

Formulari de contacte

Coneix l’IDIBGI!

menu